Sutent (
Sunitinib) is an expensive drug that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat specific digestive tract tumors called
GISTs, advanced
kidney cancer, and certain pancreatic
neuroendocrine tumors. It is less popular than comparable drugs. While 99% of insurance plans cover the most common version of Sutent at a co-pay of $32.50-$60.00, many of them have restrictions.
With the Patient Assistance Program from PAN Foundation, contact the program to see how they can financially help you out.
You can save more on select medications with GoodRx Companion. See which medications are eligible.